{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:10:50Z","timestamp":1778832650421,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anndiagpath.2026.152650","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:46:04Z","timestamp":1777308364000},"page":"152650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Follicular lymphoma with EBV-associated transformation, a single institution experience"],"prefix":"10.1016","volume":"83","author":[{"given":"Jacob","family":"Rattin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve M.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2026.152650_bb0005","series-title":"Haematolymphoid tumours, WHO Classification of Tumours, 5th Edition, Volume 11","volume":"11","year":"2024"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152650_bb0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.hoc.2020.02.001","article-title":"Epidemiology of follicular lymphoma","volume":"34","author":"Cerhan","year":"2020","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152650_bb0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.25696","article-title":"Follicular lymphoma: 2020 update on diagnosis and management","volume":"95","author":"Freedman","year":"2020","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152650_bb0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152650_bb0025","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.anndiagpath.2026.152650_bb0030","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic specialized program of research excellence molecular epidemiology resource","volume":"31","author":"Link","year":"2013","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.anndiagpath.2026.152650_bb0035","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.anndiagpath.2026.152650_bb0040","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1182\/blood.2024026016","article-title":"An updated understanding of follicular lymphoma transformation","volume":"146","author":"Parry","year":"2025","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152650_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-020-00340-z","article-title":"Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups","volume":"10","author":"Batlevi","year":"2020","journal-title":"Blood Cancer J"},{"issue":"28","key":"10.1016\/j.anndiagpath.2026.152650_bb0050","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1200\/JCO.22.00843","article-title":"Six-year results from RELEVANCE: Lenalidomide plus rituximab (R(2)) versus rituximab-chemotherapy followed by rituximab maintenance in untreated advanced follicular lymphoma","volume":"40","author":"Morschhauser","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152650_bb0055","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2352-3026(18)30090-5","article-title":"Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis","volume":"5","author":"Federico","year":"2018","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152650_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bjh.14831","article-title":"Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group","volume":"178","author":"Alonso-Alvarez","year":"2017","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152650_bb0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood.2022018719","article-title":"Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns","volume":"142","author":"Dreval","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152650_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/annonc\/mdn657","article-title":"The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)","volume":"20","author":"Noy","year":"2009","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152650_bb0075","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ajcp\/aqad042","article-title":"Progression of follicular lymphoma and related entities: report from the 2021 SH\/EAHP workshop","volume":"159","author":"Duffield","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152650_bb0080","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0000000000002225","article-title":"Patients with classic Hodgkin lymphoma and follicular lymphoma compared to single malignancy controls","volume":"48","author":"Cotta","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152650_bb0085","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1200\/JCO.2012.43.2377","article-title":"Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma","volume":"31","author":"Menon","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152650_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3960\/jslrt.47.9","article-title":"Demonstration of chimeric DNA of bcl-2 and immunoglobulin heavy chain in follicular lymphoma and subsequent Hodgkin lymphoma from the same patient","volume":"47","author":"Nakamura","year":"2007","journal-title":"J Clin Exp Hematop"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152650_bb0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAS.0000000000001780","article-title":"Plasticity of mature B cells between follicular and classic Hodgkin lymphomas: a series of 22 cases expanding the spectrum of transdifferentiation","volume":"46","author":"Trecourt","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152650_bb0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1309\/AJCPWY1SGJ9IEAOR","article-title":"Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement","volume":"134","author":"Ouansafi","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152650_bb0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.humpath.2014.10.021","article-title":"Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients","volume":"46","author":"Geyer","year":"2015","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2026.152650_bb0110","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/leu.2014.167","article-title":"Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor","volume":"28","author":"Brunner","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152650_bb0115","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","article-title":"Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone","volume":"111","author":"Feldman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0120","article-title":"Secondary Hemophagocytic Lymphohistiocytosis with Epstein-Barr virus-associated transformed follicular lymphoma: a case report and literature review","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152650_bb0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/his.14379","article-title":"The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment","volume":"79","author":"Ababneh","year":"2021","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152650_bb0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/10668969241266933","article-title":"Clinicopathologic insights and molecular oncogenesis: understanding Epstein-Barr virus-induced B-cell lymphoproliferations","volume":"33","author":"Bronson","year":"2025","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152650_bb0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2011.03.003","article-title":"Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients","volume":"305","author":"Cesarman","year":"2011","journal-title":"Cancer Lett"},{"issue":"32","key":"10.1016\/j.anndiagpath.2026.152650_bb0145","doi-asserted-by":"crossref","first-page":"33849","DOI":"10.18632\/oncotarget.5292","article-title":"Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage","volume":"6","author":"Crane","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0150","article-title":"Composite lymphoma with follicular lymphoma transformation to clonally related Epstein-Barr virus (EBV) positive diffuse large B-cell lymphoma and EBV-PositiveClassic Hodgkin lymphoma","volume":"2023","author":"Ryder","year":"2023","journal-title":"Case Rep Hematol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152650_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.5060","article-title":"Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia","volume":"245","author":"Garcia-Barchino","year":"2018","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152650_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<99::AID-AJH3>3.0.CO;2-T","article-title":"Epstein-Barr virus infection in Richter's transformation","volume":"60","author":"Ansell","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-9378-5-22","article-title":"Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor?","volume":"5","author":"Dolcetti","year":"2010","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-025-04377-y","article-title":"EBV-associated histological transformation of marginal zone lymphomas: two case reports and a literature review","author":"Naito","year":"2026","journal-title":"Virchows Arch"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152650_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051825","article-title":"Immune response dysfunction in chronic lymphocytic leukemia: dissecting molecular mechanisms and microenvironmental conditions","volume":"21","author":"Arruga","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152650_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.5060","article-title":"Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia","volume":"245","author":"Garcia-Barchino","year":"2018","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152650_bb0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2141.2001.02579.x","article-title":"Epstein-Barr virus-positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma","volume":"112","author":"Orlandi","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152650_bb0190","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3960\/jslrt.23060","article-title":"Follicular lymphoma with Epstein-Barr virus-associated transformation: a case report and review of the literature","volume":"64","author":"Tsuyuki","year":"2024","journal-title":"J Clin Exp Hematop"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152650_bb0195","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.3324\/haematol.2018.215053","article-title":"Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature","volume":"104","author":"Granai","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpi.2025.100436","article-title":"PIRO: a web-based search platform for pathology reports, leveraging large language models to generate discrete searchable insights","volume":"17","author":"Robertson","year":"2025","journal-title":"J Pathol Inform"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571166","article-title":"Reversal of immunity after clearance of chronic HCV infection-all reset?","volume":"11","author":"Wedemeyer","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152650_bb0210","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41591-019-0523-2","article-title":"A case report of clonal EBV-like memory CD4(+) T cell activation in fatal checkpoint inhibitor-induced encephalitis","volume":"25","author":"Johnson","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152650_bb0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12272-024-01529-7","article-title":"Immunosenescence and age-related immune cells: causes of age-related diseases","volume":"48","author":"Kim","year":"2025","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0220","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"585","author":"Swerdlow","year":"2017"},{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152650_bb0225","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152650_bb0230","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152650_bb0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/ijmr.IJMR_1387_17","article-title":"A juggernaut of innate & adaptive immune cells in chronic hepatitis C","volume":"151","author":"Tomer","year":"2020","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0240","article-title":"A rare case of Pembrolizumab-induced reactivation of Hepatitis B","volume":"2018","author":"Pandey","year":"2018","journal-title":"Case Rep Oncol Med"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152650_bb0245","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.5858\/arpa.2023-0056-RA","article-title":"Cancer biomarkers V: update on B-cell lymphoma biomarkers","volume":"148","author":"Crane","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","article-title":"Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion","volume":"55","author":"Xiao","year":"2016","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152650_bb0255","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/ajcp\/aqad027","article-title":"Progression and transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: report from the 2021 SH\/EAHP workshop","volume":"159","author":"Czader","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152650_bb0260","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.2016.214","article-title":"Epstein-Barr virus-positive follicular lymphoma","volume":"30","author":"Mackrides","year":"2017","journal-title":"Mod Pathol"},{"issue":"20","key":"10.1016\/j.anndiagpath.2026.152650_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205141","article-title":"Richter transformation in chronic lymphocytic leukemia: update in the era of novel agents","volume":"13","author":"Tadmor","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12308-022-00502-x","article-title":"EBV-positive follicular lymphoma and concurrent EBV-negative diffuse large B-cell lymphoma illustrating branched evolution model and \u201chit and run\u201d hypothesis","volume":"15","author":"Kitagawa","year":"2022","journal-title":"Journal of Hematopathology"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152650_bb0275","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41379-020-0575-3","article-title":"Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas","volume":"33","author":"Mundo","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152650_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1742214","article-title":"Hit-and-run hypothesis: revisiting the impact of EBV in malignancies","volume":"17","author":"Mangiaterra","year":"2026","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152650_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)64697-4","article-title":"Gammaherpesviruses and \u201chit-and-run\u201d oncogenesis","volume":"156","author":"Ambinder","year":"2000","journal-title":"Am J Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:39:43Z","timestamp":1778830783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S1092913426000468"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152650","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular lymphoma with EBV-associated transformation, a single institution experience","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152650"}}